Acetylcysteine Solution
Product Images NDC 0409-3308

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Acetylcysteine (NDC 0409-3308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Acetylcysteine (Acetylcysteine 01)

FDA Label Image

Chart Plasma Or Serum Acetaminophen Concentration V Time Post-acetaminophen Ingestion (Acetylcysteine 02)

Chart Plasma Or Serum Acetaminophen Concentration V Time Post-acetaminophen Ingestion (Acetylcysteine 02)
This is a graph that shows the concentration levels of acetaminophen in plasma or serum over time after ingestion. The x-axis shows the time in hours post-ingestion, and the y-axis shows the concentration of acetaminophen in ug/mL. There is a broken line on the graph that indicates the concentration level above which hepatotoxicity is likely. The graph suggests that acetylcysteine should be continued if the assay value falls on or above the broken line.*
FDA Label Image

Hospira Logo (Acetylcysteine 03)

FDA Label Image

Principal Display Panel (30 mL Vial Label)

Principal Display Panel (30 mL Vial Label)
This is a description of a 30 mL solution of acetylcysteine intended for inhalation as a mucolytic agent or for oral administration as an acetaminophen antidote. Each mL of the solution contains 100 mg of acetylcysteine and 0.25 mg of edetate disodium. It is not for injection and should be stored at 20-25°C or in a refrigerator at 8°C after opening. The solution may contain NaOH and HCI. The accompanying directions for dosage and indications for use should be followed. The vial must be discarded after 96 hours of opening, and a change in color may occur, but it does not affect the efficacy of the solution. The manufacturer is Hospira, Inc., and the product has an NDC code of 0409-3307-11.*
FDA Label Image

Principal Display Panel (30 mL Vial Carton)

Principal Display Panel (30 mL Vial Carton)
This is a prescription medication containing Acetylcysteine in a 30 mL solution, available for inhalation or oral administration as a mucolytic agent or acetaminophen antidote. It is not to be injected and comes with dosage and use directions. The solution is stored at controlled room temperature and should be discarded after 96 hours of opening. It may contain sodium hydroxide and hydrochloric acid for pH adjustment. This product is not available over the counter.*
FDA Label Image

Principal Display Panel (30 mL Vial Label)

Principal Display Panel (30 mL Vial Label)
This is a description of a 30mL solution of acetylcysteine for either inhalation as a mucolytic agent or for oral administration as an acetaminophen antidote. The solution contains 200mg/mL of acetylcysteine, edetate disodium, diyd0.5mg, and may contain NaOH and HCI for pH adjustment. The usual dosage should be followed in accordance with the accompanying directions for dosage and usage indications. The solution should be stored between 20 to 25°C or in the refrigerator at 2°C. A diluted solution can be used if required, within 96 hours. Changes in color after opening do not affect the drug's efficacy. The distributor of this solution is Hospira, Inc. The LOT and EXP numbers are also mentioned, and it should be discarded after use.*
FDA Label Image

Principal Display Panel (30 mL Vial Carton)

Principal Display Panel (30 mL Vial Carton)
This is a 30 mL solution of Acetylcysteine for Inhalation or Oral Administration. It is not for injection and can be diluted with an appropriate solution. The usual dosage should be seen for directions, dosage, indications and use. The drug should be stored at 20 to 25°C or 68 to 77°F and in a refrigerator at 2° to 8°C or 36° to 46°F after opening. The opened vial should be discarded after 96 hours. The drug contains sodium hydroxide and may contain hydrochloric acid for PH adjustment. It is distributed by Hospira, Inc. and the lot number is #HH#HH#AA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.